Home Zee newd Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Read

Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19.

from Zee News :India National https://ift.tt/3yhEwmL

No comments:

Subscribe to: Post Comments ( Atom )